These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 15172634)

  • 61. [Possible applications for monoclonal antibodies in diagnosis and therapy of head and neck cancers. II. Future role].
    Wustrow TP
    HNO; 1991 Apr; 39(4):121-8. PubMed ID: 2066263
    [TBL] [Abstract][Full Text] [Related]  

  • 62. "Skip metastases" from head and neck cancers.
    Ferlito A; Shaha AR; Rinaldo A; Pellitteri PK; Mondin V; Byers RM
    Acta Otolaryngol; 2002 Oct; 122(7):788-91. PubMed ID: 12484658
    [No Abstract]   [Full Text] [Related]  

  • 63. Occult neck disease in stage I anterior lingual cancer.
    Dunn CW; Kennedy TL
    Trans Pa Acad Ophthalmol Otolaryngol; 1986; 38(2):459-63. PubMed ID: 3824452
    [No Abstract]   [Full Text] [Related]  

  • 64. Prognostic variables in head and neck cancer. Tumor site, stage, nodal status, differentiation, and immune status.
    Davis RK
    Otolaryngol Clin North Am; 1985 Aug; 18(3):411-9. PubMed ID: 4047665
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Determination of plasminogen activator of the head and neck tumor tissue].
    Ji X; Nong H; Huang G
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1994; 29(5):299-301. PubMed ID: 7718296
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Role of molecular markers in the management of head and neck cancers.
    Ferreira MB; De Souza JA; Cohen EE
    Curr Opin Oncol; 2011 May; 23(3):259-64. PubMed ID: 21358329
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Future of the TNM classification and staging system in head and neck cancer.
    Takes RP; Rinaldo A; Silver CE; Piccirillo JF; Haigentz M; Suárez C; Van der Poorten V; Hermans R; Rodrigo JP; Devaney KO; Ferlito A
    Head Neck; 2010 Dec; 32(12):1693-711. PubMed ID: 20191627
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Anatomic and histopathologic factors that influence the occurrence of cervical metastasis of head and neck carcinoma.
    Kanda JL
    Rev Paul Med; 1993; 111(4):11-4. PubMed ID: 8108639
    [No Abstract]   [Full Text] [Related]  

  • 69. [Prognosis for the metastasis of squamous cell carcinoma of the head and neck].
    Kakurina GV; Kondakova IV; Choĭnzonov EL
    Vopr Onkol; 2012; 58(1):26-32. PubMed ID: 22629824
    [No Abstract]   [Full Text] [Related]  

  • 70. Cervical lymphatics and squamous cell carcinoma of the head and neck: biologic significance and therapeutic considerations.
    Carlson GW
    Surg Oncol Clin N Am; 1996 Jan; 5(1):65-77. PubMed ID: 8789494
    [No Abstract]   [Full Text] [Related]  

  • 71. [Molecular markers study in pTNM of squamous carcinoma of the head and neck].
    Cortesina G; Rosso P; Mola P; Ricci E; Cavalot AL; Martone T; Comoglio PM; Di Renzo F
    Acta Otorhinolaryngol Ital; 2000 Dec; 20(6):380-2. PubMed ID: 11398672
    [No Abstract]   [Full Text] [Related]  

  • 72. Evaluation and staging of the neck in patients with malignant disease.
    Shum JW; Dierks EJ
    Oral Maxillofac Surg Clin North Am; 2014 May; 26(2):209-21. PubMed ID: 24656885
    [TBL] [Abstract][Full Text] [Related]  

  • 73. How will increasing our knowledge of the head and neck cancer cells' secretome benefit head and neck squamous cell carcinoma patients?
    Ralhan R
    Expert Rev Proteomics; 2012 Apr; 9(2):115-8. PubMed ID: 22462781
    [No Abstract]   [Full Text] [Related]  

  • 74. Micrometastasis in head and neck squamous cell carcinoma.
    Augustine D; Patil S; Rao RS
    J Contemp Dent Pract; 2014 Nov; 15(6):i. PubMed ID: 25825117
    [No Abstract]   [Full Text] [Related]  

  • 75. Correspondence re: S. Maula et al., intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinoma of the head and neck. Cancer Res., 63: 1920-1926, 2003.
    Padera TP; Boucher Y; Jain RK
    Cancer Res; 2003 Dec; 63(23):8555-6; author reply 8558. PubMed ID: 14679026
    [No Abstract]   [Full Text] [Related]  

  • 76. Pathology of squamous cell carcinomas of the head and neck.
    Carter RL
    Curr Opin Oncol; 1990 Jun; 2(3):552-6. PubMed ID: 2092773
    [No Abstract]   [Full Text] [Related]  

  • 77. [Quality control in pathology and theranostics in head and neck cancers].
    Faure C; Badoual C; Fleury B; Milano G; Thariat J
    Bull Cancer; 2014 May; 101(5):461-8. PubMed ID: 24886897
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Prognostic factors in oral, head, and neck cancer.
    McGuff HS; Aufdemorte TB
    Tex Dent J; 1998 Jun; 115(6):31-5. PubMed ID: 9667210
    [No Abstract]   [Full Text] [Related]  

  • 79. Squamous cell carcinoma of the head and neck. Part I. Epidemiology, etiology, staging and diagnosis.
    Bergman SA; Page LR; Elias EG
    J Md State Dent Assoc; 1981 Dec; 24(3):98-100. PubMed ID: 6955418
    [No Abstract]   [Full Text] [Related]  

  • 80. The surgical pathology of head and neck cancer.
    Zarbo RJ; Crissman JD
    Semin Oncol; 1988 Feb; 15(1):10-9. PubMed ID: 3278387
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.